Clincosm LogoSign in Get a demo

Post-acute Care for Patients With Frailty

Sponsor
Taipei City Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05452395
Collaborator
(none)
254
Enrollment
1
Location
2
Arms
6.4
Actual Duration (Months)
39.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. However, few studies investigated the effects of post-acute care (PAC) in frail older patients who just recovered from acute hospitalization. This study aimed to evaluate the effects of PAC on frail older adults in Taiwan.

Condition or Disease Intervention/Treatment Phase
  • Other: Post-acute care
 N/A

Detailed Description

Frail patients aged >= 75 were recruited and divided into PAC or control groups. The PAC group received comprehensive geriatric assessment (CGA) and multifactorial intervention for two to four weeks. The control group received CGA only. The primary outcomes were 90-day emergency room visits, readmissions, and mortality after PAC.

Study Design

Study Type:
Interventional
Actual Enrollment :
254 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Integrated Post-Acute Care Program for Frail Elderly
Actual Study Start Date :
Jun 19, 2020
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Post-acute care

comprehensive geriatric assessment, and either home-based or hospital-based post-acute care

Other: Post-acute care
A personalized care program, focusing on managing geriatric syndromes and improving functional performances. Strength training, activities of daily living (ADL) and instrumental activities of daily living (IADL) practice, basic mobility training, reconditioning exercise, and home environment assessment and modification.
No Intervention: control group

comprehensive geriatric assessment only

Outcome Measures

Primary Outcome Measures

  1. 90-day emergency room visits [90 days after post-acute care]

    Emergency room visits after post-acute care

  2. 90-day readmissions [90 days after post-acute care]

    Readmissions visits after post-acute care

  3. 90-day mortality [90 days after post-acute care]

    Mortality after post-acute care

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  1. Mild to severe frailty identified by the Clinical Frailty Scale

  2. Age ≥ 75 years

  3. Diagnosis with Parkinson's disease, dementia, chronic obstructive pulmonary disease, or chronic kidney disease stage three or worse

  4. Acute hospital stays between 3 to 30 days with deconditioning

  5. Stable medical condition with no need of intensive care, laboratory examination, or oxygen dependence

Exclusion Criteria:

  1. Refused to participate in the program

  2. Candidate for other post-acute care programs (i.e. stroke, traumatic neurological injury, or fracture)

  3. Unable to cooperate with the program due to mental or cognitive impairment

  4. Long-term ventilator-dependence

  5. Long-term bed-ridden status (> 6 months)

  6. Diagnosed as end of life and in need of palliative care

  7. Diagnosed as major illness (i.e. end-stage renal disease) and in need of frequent inpatient treatment ( > 3 times over recent 6 months)

  8. Institutional residents

  9. Home medical care participants

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei City Hospital Taipei City Taiwan

Sponsors and Collaborators

  • Taipei City Hospital

Investigators

  • Principal Investigator: Tai-Yin Wu, PhD, Department of Family Medicine, Taipei City Hospital, Zhongxing Branch

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tai-Yin Wu, Doctor, Taipei City Hospital
ClinicalTrials.gov Identifier:
NCT05452395
Other Study ID Numbers:
  • TPECH-frailty
First Posted:
Jul 11, 2022
Last Update Posted:
Jul 11, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Frailty

Study Results

No Results Posted as of Jul 11, 2022